News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
642,522 Results
Type
Article (52832)
Company Profile (181)
Press Release (589509)
Section
Business (184076)
Career Advice (2764)
Deals (33771)
Drug Delivery (108)
Drug Development (79148)
Employer Resources (166)
FDA (16462)
Job Trends (15288)
News (322556)
Policy (32690)
Tag
Academia (2830)
Alliances (46656)
Alzheimer's disease (1343)
Approvals (16391)
Artificial intelligence (195)
Bankruptcy (341)
Best Places to Work (11635)
Biotechnology (126)
Breast cancer (224)
Cancer (1649)
Cardiovascular disease (139)
Career advice (2327)
CAR-T (123)
Cell therapy (346)
Clinical research (63751)
Collaboration (634)
Compensation (150)
COVID-19 (2799)
C-suite (152)
Data (1513)
Diabetes (204)
Diagnostics (6332)
Earnings (69470)
Employer resources (149)
Events (86945)
Executive appointments (539)
FDA (17280)
Funding (548)
Gene therapy (245)
GLP-1 (725)
Government (4721)
Healthcare (18929)
Infectious disease (2906)
Inflammatory bowel disease (120)
Interviews (511)
IPO (14967)
Job creations (4051)
Job search strategy (1948)
Layoffs (493)
Legal (7503)
Lung cancer (245)
Manufacturing (230)
Medical device (13327)
Medtech (13332)
Mergers & acquisitions (19073)
Metabolic disorders (563)
Neuroscience (1752)
NextGen: Class of 2025 (6809)
Non-profit (4861)
Northern California (1824)
Obesity (323)
Opinion (233)
Patents (135)
People (54700)
Phase I (19780)
Phase II (27859)
Phase III (21339)
Pipeline (645)
Postmarket research (2585)
Preclinical (7698)
Radiopharmaceuticals (230)
Rare diseases (319)
Real estate (5738)
Regulatory (22169)
Research institute (2514)
Resumes & cover letters (424)
Southern California (1636)
Startups (3586)
United States (15961)
Vaccines (684)
Weight loss (241)
Date
Today (130)
Last 7 days (572)
Last 30 days (2522)
Last 365 days (33136)
2025 (2522)
2024 (33562)
2023 (38279)
2022 (48997)
2021 (53442)
2020 (53159)
2019 (46991)
2018 (36090)
2017 (32833)
2016 (31882)
2015 (36111)
2014 (27762)
2013 (22934)
2012 (24678)
2011 (25438)
2010 (22771)
Location
Africa (930)
Arizona (157)
Asia (38513)
Australia (6604)
California (4248)
Canada (1416)
China (353)
Colorado (198)
Connecticut (198)
Europe (87958)
Florida (580)
Georgia (147)
Illinois (425)
Indiana (244)
Maryland (681)
Massachusetts (2904)
Michigan (186)
Minnesota (299)
New Jersey (1121)
New York (1169)
North Carolina (791)
Northern California (1824)
Ohio (148)
Pennsylvania (886)
South America (1296)
Southern California (1636)
Texas (586)
Utah (135)
Washington State (408)
642,522 Results for "ferring holding sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Pharm Country
Ferring Pharmaceuticals and Posterity Health Launch New Partnership to Activate Men About Their Fertility
Ferring Pharmaceuticals today launched a new Male Fertility program on Ferring’s Fertility Out Loud platform that empowers men to take the initiative to understand their fertility status.
June 20, 2024
·
4 min read
Press Releases
Ferring Highlights Commitment to C. Diff Infection Community on the Second Anniversary of the Launch of REBYOTA® (fecal microbiota, live – jslm)
January 27, 2025
·
7 min read
Press Releases
Genpact Announces Renewed Partnership with Ferring Pharmaceuticals
November 21, 2024
·
2 min read
Business
Ferring Pharmaceuticals and SK Pharmteco Enter into Commercial Gene Therapy Manufacturing Deal
Ferring Pharmaceuticals and SK pharmteco today announced an agreement to scale up commercial manufacturing capacity for the drug substance of Ferring’s intravesical non-replicating gene therapy ADSTILADRIN (nadofaragene firadenovec-vncg) for ensuring long-term future supply.
April 18, 2024
·
10 min read
Press Releases
Ferring Advances Three Studies in ADSTILADRIN® (nadofaragene firadenovec-vncg) Clinical Trial Program
December 3, 2024
·
16 min read
Press Releases
Ferring Announces U.S. FDA Advisory Committee Meeting for SI-6603 (condoliase), An Investigational Treatment in Lumbar Disc Herniation
December 2, 2024
·
3 min read
Pharm Country
Ferring to Present New Data Analyses at ASPN 2024 for SI-6603, an Investigational Treatment for Lumbar Disc Herniation
Ferring Pharmaceuticals today announced the presentation of two analyses of data at the American Society of Pain and Neuroscience (ASPN) 2024 Annual Meeting, for SI-6603, an investigational therapy intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
June 24, 2024
·
3 min read
Pharm Country
Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603 (condoliase), in Lumbar Disc Herniation at ASIPP 2024
Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced the presentation of data looking at the efficacy and safety profile of SI-6603 (generic name: condoliase), an investigational product intended to treat radicular leg pain associated with lumbar disc herniation (LDH).
April 8, 2024
·
9 min read
1 of 64,253
Next
